The PRMT5-splicing axis is a critical oncogenic vulnerability that regulates detained intron splicing
Open Access
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institute of General Medical Sciences (5T32GM136540)
- National Cancer Institute (P30-CA014051)
- National Cancer Institute (NCI-5P01CA042063-35)
- National Institutes of Health (GM141544)
This publication has 57 references indexed in Scilit:
- Molecular basis for substrate recruitment to the PRMT5 methylosomeMolecular Cell, 2021
- PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem CellsCell Reports, 2019
- PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying EnzymesCell Reports, 2018
- Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant GliomaCancer Cell, 2017
- A Detailed Protocol for Subcellular RNA Sequencing (subRNA‐seq)Current Protocols in Molecular Biology, 2017
- A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL modelsNature Chemical Biology, 2015
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyondCellular and Molecular Life Sciences, 2015
- Suppression of lung adenocarcinoma progression by Nkx2-1Nature, 2011
- Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pIClnCurrent Biology, 2001
- Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN proteinRNA, 2001